Transforming science into business with impact

Get to know us

Transforming science into business with impact

We are a Venture Capital, supporting the development of scientific and technological startups, and we are driven by revolutionary ideas that solve the greatest problems posed by modern life.

We understand that knowledge and talent are crucial factors in creating change and progress in our society.

Turning ideas into startups is a winding but exciting road… and we love it! Therefore, if you have an innovative idea and share our passions, come join our path! We are sure that investments alone are not enough, that is why we are willing to open our doors and lend a helping hand to you, entrepreneurs.

We invest in DeepTech

Deep technology was impossible in the past, it is barely feasible today, and may soon become so persistent and impactful to the point we can hardly remember life without it.

Investment

Up to USD 750.000 (Seed)
Up to USD 600.000 (Follow-on)

Active Management

Management team available for the startup

Connections

Access to global networks of mentors, strategic partners, experts, entrepreneurs, and investors

Infrastructure

Fab-lab, wet-lab and spin-off labs. Co-working spaces and private offices in Sunchales, CABA and Bariloche

MedTech

Robotics

We are a team

We are an experienced and multidisciplinary team, focused on addressing both technological and business challenges.

Nicolás Tognalli

Founder & Managing Partner

Oren Gershtein

Partner

Juan María Massot

Investment Manager

Jose María Rodriguez

Business Development Manager

Laura Gé

Business & Investment Advisor

Fernando Molinari

Analyst

Mauricio Grisolia

Analyst

Leandro Seguro

Controller

Carolina Ponso

Administration Officer

Carolina Giusti

Counselor

María Clara Sasia

MKT & Comm

25+
patents in progress

100+
linked scientists

15
invested companies

See our portfolio

Visit

We wouldn`t know how to describe in short and simple words what CITES has contributed and continues to contribute to our startup.

In our experience, CITES is a great alternative to translate our ideas into reality, after having worked on developing and planning them for so long, so we can start to walk down the right path to real impact.

With CITES, we have been able to take our academic research to the entrepreneurial world, hand in hand with the growth of our startup, and promoting its development, following an efficient model that puts us in a good position at an international level.

CITES has become a technological partner who was much more than an investor; they helped us from scratch to improve the idea and the prototype and with them we were able to build GBOT.

CITES' expertise and advice was key to the establishment and success of Ergo. They even worked hard on refining our strategy and business plan prior to the investment committee.

CITES was an ally who helped us transform our scientific research into an innovative therapy. Being part of its ecosystem, working as a team day by day, provides continuous learning that turns each challenge into an enjoyable job.

Incubating in CITES was the right decision. We are convinced that coming across CITES was a catalyst to accelerate the startup and be one step closer to fulfilling our dream: starting clinical trials in humans with an innovative drug.

CITES has been an excellent early stage investor/partner providing not only financial support but very useful advice and relationships. The highly experienced team has been extremely useful in navigating the complex pathway for an early stage venture in managing both the Argentine and international commercial environment.

The start up journey is not a straight line and the true colors and maturity of any investor shows over time and especially when there are more difficult decisions to be made. CITES and Nicolás Tognalli come through with flying colors. CITES is a proactive, value-added investor, a pleasure to work with and a great partner.

We wouldn`t know how to describe in short and simple words what CITES has contributed and continues to contribute to our startup.

In our experience, CITES is a great alternative to translate our ideas into reality, after having worked on developing and planning them for so long, so we can start to walk down the right path to real impact.

With CITES, we have been able to take our academic research to the entrepreneurial world, hand in hand with the growth of our startup, and promoting its development, following an efficient model that puts us in a good position at an international level.

CITES has become a technological partner who was much more than an investor; they helped us from scratch to improve the idea and the prototype and with them we were able to build GBOT.

CITES' expertise and advice was key to the establishment and success of Ergo. They even worked hard on refining our strategy and business plan prior to the investment committee.

CITES was an ally who helped us transform our scientific research into an innovative therapy. Being part of its ecosystem, working as a team day by day, provides continuous learning that turns each challenge into an enjoyable job.

Incubating in CITES was the right decision. We are convinced that coming across CITES was a catalyst to accelerate the startup and be one step closer to fulfilling our dream: starting clinical trials in humans with an innovative drug.

CITES has been an excellent early stage investor/partner providing not only financial support but very useful advice and relationships. The highly experienced team has been extremely useful in navigating the complex pathway for an early stage venture in managing both the Argentine and international commercial environment.

The start up journey is not a straight line and the true colors and maturity of any investor shows over time and especially when there are more difficult decisions to be made. CITES and Nicolás Tognalli come through with flying colors. CITES is a proactive, value-added investor, a pleasure to work with and a great partner.

Latest News

Emanuel Campoy CSO de Epiliquid ganó el premio Merck-CONICET

ViewMind at TBD Media Group

Medicine in the blood

Let’s make a difference

Many of the solutions to humanity’s great problems lie dormant on laboratory counters, experimental nights, and hallway talks.

CITES trusts that the only way to social, environmental and economic development in Argentina and the region is one based on science and emerging technologies.

If you are willing to get up every morning and do your part, from the south of the continent, to bridge the development gap with the rest of the planet, we will walk hand in hand with you.

Download reports

2020-2021

We are involved in The United Nations Global Compact

A special partner

To help us on this trip, we added an exceptional co-pilot… one who has already travelled the road in other latitudes in the “Startup Nation”.

Traveling from Israel to Sunchales every month, Oren Gershtein and IdealityRoads unfolded the roadmap before our eyes and accompanied us on this fascinating itinerary. They brought us industry best practices, experiences, and the know-how necessary to understand every stretch of the deep tech investment map.

Since 2014, IdealityRoads has worked closely with CITES and the portfolio companies and becoming a special partner.